1
Return

Trastuzumab Deruxtecan in Residual HER2-Positive Early Breast Cancer (vol 394, pg 845, 2026)

delete2026-04-02
delete0
PRE
AI
L
Loibl, Sibylle
P
Park, Yeon Hee
S
Shao, Zhiming
H
Huang, Chiun-Sheng
B
Barrios, Carlos
J
Jame, Jame
P
Prat, Aleix
DOI:10.1056/NEJMx260006delete
deleteOriginal
deleteOriginal request for help
deleteShare
deleteSave
Abstract

Abstract

En

Journal

New England Journal of Medicine cover
New England Journal of Medicine
IF:
78.5
Papers:
2.7W
Citations:
39.7W

Organization

No organization information available
Cited Papers

Cited Papers

Citing Papers

Citing Papers